doxazosin and captopril

doxazosin has been researched along with captopril in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (47.37)18.2507
2000's6 (31.58)29.6817
2010's3 (15.79)24.3611
2020's1 (5.26)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Bender, A; Czobor, P; Jelinek, B; Málnási-Csizmadia, A; Peragovics, Á; Simon, Z; Tombor, L; Végner, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Brown, MJ; Dickerson, JE1
Canessa, ML; DeFronzo, RA; Giordano, M; Matsuda, M; Sanders, L1
Di Marino, L; Ferrara, LA; Mancini, M; Marotta, T; Russo, O1
Ittner, KP; Krämer, BK; Marienhagen, J1
Canessa, ML; Castellino, P; DeFronzo, RA; Giordano, M; Sanders, LR1
Dugal, B1
Canessa, ML; Castellino, P; DeFronzo, RA; Giordano, M; Solini, A1
Aanderud, S; Gerdts, E; Lund-Johansen, P; Myking, OL; Omvik, P; Svarstad, E1
Ritz, E; Schwenger, V; Zeier, M1
Gerdts, E; Iversen, BM; Ofstad, J; Omvik, P; Svarstad, E1

Reviews

1 review(s) available for doxazosin and captopril

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

5 trial(s) available for doxazosin and captopril

ArticleYear
Synergism between alpha 1-blockade and angiotensin converting enzyme inhibition in essential hypertension.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1991, Volume: 9, Issue:6

    Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Doxazosin; Drug Synergism; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Prazosin

1991
Doxazosin and captopril in mildly hypercholesterolemic hypertensive patients. The Doxazosin-Captopril in Hypercholesterolemic Hypertensives Study.
    Hypertension (Dallas, Tex. : 1979), 1993, Volume: 21, Issue:1

    Topics: Adult; Aged; Blood Pressure; Captopril; Doxazosin; Female; Heart Rate; Humans; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Quality of Life

1993
Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
    Nephron, 1996, Volume: 72, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Doxazosin; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypertension; Kidney; Kidney Function Tests; Male; Middle Aged; Nifedipine; Proteinuria

1996
Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment.
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:11

    Topics: Adult; Antihypertensive Agents; Antiporters; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Doxazosin; Erythrocytes; Female; Glucose; Glucose Clamp Technique; Humans; Hypertension; Insulin; Lithium; Male; Middle Aged; Nifedipine; Sodium; Sodium-Hydrogen Exchangers; Triglycerides

1997
Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for 6 months.
    American journal of hypertension, 1998, Volume: 11, Issue:10

    Topics: Adult; Albuminuria; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Doxazosin; Echocardiography; Female; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis

1998

Other Studies

13 other study(ies) available for doxazosin and captopril

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Interaction of digoxin with antihypertensive drugs via MDR1.
    Life sciences, 2002, Feb-15, Volume: 70, Issue:13

    Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors

2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
    Journal of medicinal chemistry, 2013, Nov-14, Volume: 56, Issue:21

    Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; CHO Cells; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Diabetes, 1995, Volume: 44, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Cholesterol; Diabetes Mellitus, Type 2; Doxazosin; Fatty Acids, Nonesterified; Female; Glucose; Glycated Hemoglobin; Humans; Hypertension; Insulin; Lipid Metabolism; Lipids; Male; Middle Aged; Nifedipine

1995
Diagnostic strategies in renovascular hypertension.
    Clinical nephrology, 1996, Volume: 45, Issue:2

    Topics: Captopril; Doxazosin; Humans; Hypertension, Renovascular; Radioisotope Renography; Renal Artery; Renal Artery Obstruction; Sensitivity and Specificity

1996
Renography in renovascular hypertension.
    Clinical nephrology, 1996, Volume: 46, Issue:3

    Topics: Captopril; Doxazosin; Humans; Hypertension, Renovascular; Radiography; Radioisotope Renography

1996
Antihypertensive therapy in renal patients - benefits and difficulties.
    Nephron, 1999, Volume: 83, Issue:3

    Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Diuretics; Doxazosin; Humans; Hydrochlorothiazide; Hypertension, Renal; Kidney Failure, Chronic; Kidney Glomerulus; Male; Nitrendipine; Proteinuria; Renal Circulation; Triamterene

1999
Renal hemodynamic effects of captopril and doxazosin during slight physical activity in hypertensive patients with type-1 diabetes mellitus.
    Kidney & blood pressure research, 2001, Volume: 24, Issue:1

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Doxazosin; Exercise; Female; Humans; Hypertension; Kidney; Male; Middle Aged

2001
chemdatabank.com